Related Articles
Cutaneous leukocytoclastic vasculitis associated with erlotinib treatment: A case report and review of the literature
Gastrointestinal perforation during treatment with erlotinib plus bevacizumab in two patients with non‑small cell lung cancer exhibiting epidermal growth factor receptor mutations: A case report
Atypical diffuse bilateral cystic lung changes secondary to erlotinib treatment in a patient with metastatic non‑small cell lung carcinoma: A case report and literature review
Acute myocardial infarction following erlotinib treatment for NSCLC: A case report
Rechallenge with gefitinib following severe drug‑induced hepatotoxicity in a patient with advanced non‑small cell lung cancer: A case report and literature review